Literature DB >> 7227760

Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication.

M Hayashi, H Ohnishi, Y Kawade, Y Muto, Y Takahashi.   

Abstract

Femoral arterio-venous (A-V) differences of blood free amino acids and plasma ammonia (NH3) were simultaneously determined after an overnight fast in 16 patients with decompensated liver cirrhosis in the absence and presence of encephalopathy, as compared with those in 8 control subjects. In spite of increased releases of phenylalanine (Phe) and tyrosine (Tyr) from the peripheral tissue, releases of isoleucine (Ile) and leucine (Leu) as well as alanine (Ala) were found to be significantly reduced in decompensated liver cirrhosis, particularly in the presence of hepatic encephalopathy. Furthermore, NH3 was found to be significantly taken up by the skeletal muscle of these patients, and a positive correlation was observed between arterial NH3 level and the A-V differences of Leu, of Ile and of Ala. These findings strongly suggest that net degradation (or utilization) of branched-chain amino acids (in particular, Leu and Ile) is enhanced in the muscle for detoxication of ammonia (i.e., glutamine synthesis) by supplying the carbon skeleton and energy in cirrhosis of the liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7227760     DOI: 10.1007/bf02820426

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  11 in total

1.  The free amino acids of human blood plasma.

Authors:  W H STEIN; S MOORE
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

2.  Insulin, glucagon, portal systemic shunting, and hepatic failure in the dog.

Authors:  P B Soeters; G Weir; A M Ebeid; J E Fischer
Journal:  J Surg Res       Date:  1977-09       Impact factor: 2.192

Review 3.  Regulation and significance of amino acid metabolism in skeletal muscle.

Authors:  A L Goldberg; T W Chang
Journal:  Fed Proc       Date:  1978-07

4.  Insulin in the regulation of protein turnover in heart and skeletal muscle.

Authors:  L S Jefferson; D E Rannels; B L Munger; H E Morgan
Journal:  Fed Proc       Date:  1974-04

5.  Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions.

Authors:  J E Fischer; N Yoshimura; A Aguirre; J H James; M G Cummings; R M Abel; F Deindoerfer
Journal:  Am J Surg       Date:  1974-01       Impact factor: 2.565

6.  The origin of alanine produced in skeletal muscle.

Authors:  T W Chang; A L Goldberg
Journal:  J Biol Chem       Date:  1978-05-25       Impact factor: 5.157

7.  The effect of normalization of plasma amino acids on hepatic encephalopathy in man.

Authors:  J E Fischer; H M Rosen; A M Ebeid; J H James; J M Keane; P B Soeters
Journal:  Surgery       Date:  1976-07       Impact factor: 3.982

8.  Leucine degradation in cell-free extracts of skeletal muscle.

Authors:  R Odessey; A L Goldberg
Journal:  Biochem J       Date:  1979-02-15       Impact factor: 3.857

9.  Evidence of inter-organ amino-acid transport by blood cells in humans.

Authors:  P Felig; J Wahren; L Räf
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

10.  Insulin, plasma aminoacid imbalance, and hepatic coma.

Authors:  H N Munro; J D Fernstrom; R J Wurtman
Journal:  Lancet       Date:  1975-03-29       Impact factor: 79.321

View more
  12 in total

1.  [Hepatic encephalopathy after portosystemic shunt].

Authors:  D Jentschura; L W Storz; B Rumstadt; M Winkler
Journal:  Langenbecks Arch Chir       Date:  1996

2.  Intra- and extracellular amino acid concentrations in portacaval-shunted rabbits. Role of hyperammonemia and effects of branched-chain amino acid-enriched parenteral nutrition.

Authors:  H Leweling; U Staedt; J P Striebel; R Zeitz; E Holm
Journal:  Z Ernahrungswiss       Date:  1989-06

3.  Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis.

Authors:  Cynthia Tsien; Gangarao Davuluri; Dharmvir Singh; Allawy Allawy; Gabriella A M Ten Have; Samjhana Thapaliya; John M Schulze; David Barnes; Arthur J McCullough; Marielle P K J Engelen; Nicolaas E P Deutz; Srinivasan Dasarathy
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

4.  A Metabolomic Analysis of Cirrhotic Ascites.

Authors:  Diren Beyoğlu; Cedric Simillion; Federico Storni; Andrea De Gottardi; Jeffrey R Idle
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

Review 5.  Neurological monitoring and sedation protocols in the Liver Intensive Care Unit.

Authors:  Rohit Mehtani; Shankey Garg; Kamal Kajal; Shiv Lal Soni; Madhumita Premkumar
Journal:  Metab Brain Dis       Date:  2022-04-23       Impact factor: 3.655

Review 6.  Branched-chain amino acids and muscle ammonia detoxification in cirrhosis.

Authors:  Gitte Dam; Peter Ott; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2013-01-15       Impact factor: 3.584

7.  Plasma free amino acid pattern in chronic hepatitis as a sensitive and prognostic index.

Authors:  T Kano; M Nagaki; T Takahashi; H Ohnishi; K Saitoh; K Kimura; Y Muto
Journal:  Gastroenterol Jpn       Date:  1991-06

8.  Oral supplementation with branched-chain amino acids improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis.

Authors:  K Kajiwara; M Okuno; T Kobayashi; N Honma; T Maki; M Kato; H Ohnishi; Y Muto; H Moriwaki
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

9.  Valine feeding reduces ammonia production through rearrangement of metabolic fluxes in central carbon metabolism of CHO cells.

Authors:  Iman Shahidi Pour Savizi; Nader Maghsoudi; Ehsan Motamedian; Nathan E Lewis; Seyed Abbas Shojaosadati
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-19       Impact factor: 4.813

10.  Activity of MMP1 and MMP13 and amino acid metabolism in patients with alcoholic liver cirrhosis.

Authors:  Andrzej Prystupa; Maria Szpetnar; Anna Boguszewska-Czubara; Andrzej Grzybowski; Jarosław Sak; Wojciech Załuska
Journal:  Med Sci Monit       Date:  2015-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.